MK-0616 is smashing all competitors for the prevention and treatment of atherosclerosis.
Hua Medicine has figured out how to bring type 2 diabetes mellitus into long-term and sustained remission.
Teclistamab by Johnson & Johnson is a new hope for refractory or relapsing multiple myeloma.
Roflumilast will cure plaque psoriasis in half of patients.
Tezepelumab is a powerful new drug for asthma, invented by Amgen and AstraZeneca, with a completely new mechanism of action.
A new and effective targeted therapy, being developed by Five Prime Therapeutics and Amgen, for a deadly cancer disease in the past decade.
A deadly disease and modern pharmacological attempts to treat it.